Pfizer is set to pay $340 million (€304 million) upfront to buy Therachon for its treatment for a fo
Read More
Merck & Company is planning a $1 billion expansion to its manufacturing facility in Elkton, Va. over
Read More
It feels sometimes as if Bristol-Myers Squibb’s checkpoint inhibitor Opdivo (nivolumab) is a miracul
Read More
In January, Takeda Pharmaceutical announced plans to sell about $10 billion worth of assets to offse
Read More
Excessive noise is widely known to have negative effects on health, and children in neonatal intensi
Read More
In January 2018, Civica Rx was launched by five healthcare systems as a not-for-profit generic drug
Read More
The European Commission has approved two of Celgene’s combination regimens involving Revlimid (lenal
Read More